Back to Results
First PageMeta Content
Pharmacology / Pharmaceutics / Generic drug / Public domain / Ratiopharm / Biosimilar / Abbreviated New Drug Application / Generic brand / Authorized generics / Pharmaceutical industry / Pharmaceutical sciences / Pharmaceuticals policy


Document Date: 2014-12-10 15:30:29

Open Document

File Size: 1,06 MB

Share Result on Facebook

Company

The Boston Consulting Group / Teva Pharmaceutical Industries / United Kingdom Unbranded / Poland Germany Branded / Blockbuster / France 33 25 Spain Italy Branded / Sandoz / /

Continent

Europe / /

Country

Poland / Germany / Norway / France / United States / Netherlands / Italy / United Kingdom / Spain / /

Currency

USD / /

Event

M&A / Patent Issuance / /

Facility

Pharmacy Chains / /

IndustryTerm

postpatent products / overall pharmaceutical industry / generic-pharmaceutical market / biological products / same unbranded product / generic-pharmaceutical / inhalable products / retail price / pharmaceutical sector / pharmaceutical market / or are delivered through devices / life cycle management / pharmacy chains / off-patent products / manufacturing requirements / nongeneric-pharmaceutical / pharmaceutical products / generic products / generics retail market / pharmaceutical-distribution industry / /

Organization

European Union / /

Person

Ewald Kreid / /

Position

leading advisor / /

Product

Captopril / /

Region

Nordic countries / /

SocialTag